SU1470182A3 - Способ получени амидов - Google Patents
Способ получени амидов Download PDFInfo
- Publication number
- SU1470182A3 SU1470182A3 SU874202297A SU4202297A SU1470182A3 SU 1470182 A3 SU1470182 A3 SU 1470182A3 SU 874202297 A SU874202297 A SU 874202297A SU 4202297 A SU4202297 A SU 4202297A SU 1470182 A3 SU1470182 A3 SU 1470182A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- alkyl
- phenyl
- respect
- ortho
- para position
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C07D239/82—Oxygen atoms with an aryl radical attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Quinoline Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Description
(21)4202297/23-04 (62) 4027526/23-04
(22)06.04.87
(23)29.05.86
(31)8508111
(32)30.05.85
(33)FR
(46) 30.03.89. Бкш. № 12
(71)Рон-Пуленк Сайте (FR)
(72)Хесус Бенавид (ES), Мари-Кристин Дюбрёк, Жерар Ле Фюр
и Кристиан Рено (FR)
(53)547.781.785.07(088.8)
(56)Beйгaнд-XильгeтaJг. Методы эксперимента в органической химии. М.: Хими , 1968, с. 765.
(54)СПОСОБ ПОЛУЧЕНИЯ АМИДОВ
(57)Изобретение-относитс к гетероциклическим соединени м, в частности
к получению амидов формулы I
CH ClIj -CH CH C C-N CZ--CH C(M), гдеМ
X-CO-N(R)(Rj), где Z - радикал фенила, R, и Rj идентичны и означают С,-С -алкильную, пр мую, X-CH-Rj- группу, Rj - С,-С,-алкильную группу, которые используютс как анксиолити- ческие, противосудорожные средства, средства против одьпики и дл лечени состо ни иммунодепрессии. Цель - вьшвление новых более активных соединений . Получение их ведут алкили- рованием соединени формулы I, где М CH,-CO-N(R,)(RJ, а R,, R, и Z указаны выше, соединением формулы R - Hal, где R- указано вьше, Hal - атом гал;огена. Вьщеление целевого продукта ведут известными приемами.
1
Изобретение относитс к способу получение новых амидов, которые могут примен тьс как анксиолитические средства, противосудорожные средства, средства против одьппки и дл лечени состо ни иммунодепрессии.
Цель изобретени - синтез новых амидов, которые по своей активности превосход т структурные аналоги, обладающие тем же видом активности.
Ц р и М е р. К 25 см сухого тет- рагидрофурана в атмосфере азота добавл ют 1,84 см диизопропиламина. Раствор перемешивают, охлаждают до и ввод т в него, в течение 10 мин 7 см раствора 1,6-мол рного бутйллити в гексане.
После стабилизации температуры при -70°С ввод т раствор 2,4 г N,N-диэтйл-2-фeшm-4-xинoлин-aцeтaми- да в 10 см тетрагидрофурана. Оставл ют на 30 мин при перемешивании при -70 С, затем медленно добавл ют раствор 0,58 см йодистого металла в 10 см тетрагидрофурана и 0,52 см гексаметилфосфорамида. Перемешивают 3 ч при -70°С, затем 30 мин при -50°С. Потом добавл ют по капл м 3 см абсолютного этанола, затем 2 см лед ной уксусной кислоты. Довод т температуру до О С, затем добавл ют 50 см воды и зкстрагируют 3 раза 50 см этилового эфира. Органкчес - кую фазу промывак)т водой, сушат на
сульфате магни и вьтаривают при пониженном давлении.
После перекристаллизации остатка из иэопропилового эфира получают 1,65 г Н,К-диэтил-о(,-метил-2-фенил- -4-хинолин-ацетамида с т.пл. .
N,N-Диэтил-2-фeнил-4-xинoлин-aцeт амид может быть получен следующим образом .
Смесь 3 г 2-фенил-4--хинолиН этил- ацетата и 60 см диэтиламина нагревают до 250 с в течение 40 ч. После |охлаждени избыток диэтиламина выпа- 1ривают,
Остаток хроматографируют на сили- |кагеле со смесью циклогексана - этил |ацетата (50:50 по объему) в качестве растворител . После перекристаллиза- |ции из этилацетата выдел ют 2,05 г И,Ы-диэтил-2-фенил-4-хинолин-ацет- ;амида с т.пл. 86°С. .
2-Фенил-4-хинолин этилацетат получают следующим способом.. : К 40 см сухого тетрагидрофурана в атмосфере азота добавл ют 12,9 см циизопропиламина. Раствор перемешивают , затем охлаждают до --70°С. Пото ввод т за 15 мин 46 см 1., 6-мол рно- ро раствора бутиллити н гексане, |затем после стабилизатдаи температуры |цо -60 С ввод т за 15 мин 8,1 г 2-фе Ииллепидина в 20 см тетрагидрофура- а, потом довод т до комнатной тем- Ьературы (приблизительно 20°С). Этот t acTBop добавл ют по капл м в атмосфере азота к раствору 9 см диэтил- Карбоната в 50 см тетрагидрофурана, Предварительно охлажденного до -20 С. После окончани ввещени оставл ют при перемешивании при комнат йой температуре (приблизительно 20 с) В течение 1 ч.
Затем добавл ют по капл м 25 см абсолютного этанола, потом 10 см Лед ной уксусной кислоты и, наконец, 100 см воды. Тетрагидрофуран выпаривают при пониженном давлении и :Водную фазу поглощают в 200 см эти- Лового эфира. Эфирную фазу промывают Водой, сушат на сульфате магни и Эьшарив ают при понгокенном давлении. Остаток поглощают 100 ск толуола, :Который снова выпаривают, чтобы удалить уксусную кислоту.
Остаток хроматографируют на сили- жагеле со смесью циклогексана - этил - ацетата (80:10 по объемзО в качестве Э ствог)ител . Получают 7 г 2-фенил-4-хинолин-этилацетата в форме желтого масла. Этот продукт ввод т в ацетон и после присоединени раствора сол ной кислоты в этиловом эфире выдел ют 5,13 г хлоргидрата-;2-фенил- -4-хинолин-этилацетата с т.пл. 180°С. Предлагаемые соединени и их соли имеют интересные фармакологические IQ свойства. Эти соединени св зываютс с рецепторами бензодиазепинов периферического типа, следовательно, примен ютс как анксиолитические средства, противосудорожные средства, средства J5 против одьппки и дл лечени состо ни иммунодепрессии.
Действие предлагаемых соединений определ ли, использу известный метод , на мембранах почки крысы с ис- 0 пользованием Н-РК 11195 (Ы-метил-Ы- -(1-метил-пропил)-1-(2-хлор-фенил- -З-изохинолин-карбоксамидом) в качестве лиганда. Сродство составл ет от 0,001 до ,5щH.
5 Измер ли способность соединений .смещать Н-РК 11195 с его места св зи и выражали ее величицой КГ, которую вычисл ли по формуле
0 Ki --I-Cl.,
1
о где С - концентраци используемого
Н-РК 11195,
Кд константа сродства Н-РК 5 11195J
ТСдд - концентраци соединени ,.необходима , чтобы получить торможение 50% св зи Н-РК 11195.
Соединение примера 1 имеет Ki 0,028|КМ. .
Предлагае1- иые соединени икеют небольшую токсичность. Их при оральном введении соединени мыши 5 Bbmie 200 мг/кг. ДЦ, вычисл ли после 3 дней наблюдени кумул тивным методом .
Таким образом, соединение форму- лы I имеет Ki 0,028 |уМ, а известное N,N-димeтил-фeнил-2-xинoлинкapбoк- самид-4-имеет Ki вьпие 1 р М. Следовательно , предлагаемые соединени более активны, чем известные.
0
55
Claims (1)
- Формула изо бретениСпособ получени амидов общей формулыJL-CO-NRIN, N Zгде фенилуR, и Rj,-одинаковые и означают алкильную , пр мую, содержащую ,« где R , R и Z имеют указанные зна- 1-6 атомов углерода группу;чени ,соединением общей формулыX - CH-Rj-rpynna; Rj - алкильна группа, содержаща 1-3 атома углерода,R,-Halгде R3 имеет указанные значени ;отличающийс тем, что, -g Hal - галоген, йлкилируют соединение общей формулы и выдел ют целевой продукт.6C Z-CO-lfRIR,-Halгде R3 имеет указанные значени ;
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR858508111A FR2582514B1 (fr) | 1985-05-30 | 1985-05-30 | Medicaments a base d'amides, nouveaux amides et leur preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1470182A3 true SU1470182A3 (ru) | 1989-03-30 |
Family
ID=9319678
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU864027667A SU1508957A3 (ru) | 1985-05-30 | 1986-05-29 | Способ получени амидных производных хинолина или их солей с кислотами |
SU864027526A SU1440342A3 (ru) | 1985-05-30 | 1986-05-29 | Способ получени амидов или их кислотноаддитивных солей |
SU874202112A SU1470183A3 (ru) | 1985-05-30 | 1987-03-09 | Способ получени амидных производных хинолина или их солей присоединени кислоты |
SU874202412A SU1614759A3 (ru) | 1985-05-30 | 1987-04-06 | Способ получени амидов, их диастериомеров, рацематов, энантиомеров или их аддитивных солей |
SU874202398A SU1537135A3 (ru) | 1985-05-30 | 1987-04-06 | Способ получени амидов хиназолина |
SU874202297A SU1470182A3 (ru) | 1985-05-30 | 1987-04-06 | Способ получени амидов |
SU874202362A SU1544186A3 (ru) | 1985-05-30 | 1987-04-06 | Способ получени амидов |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU864027667A SU1508957A3 (ru) | 1985-05-30 | 1986-05-29 | Способ получени амидных производных хинолина или их солей с кислотами |
SU864027526A SU1440342A3 (ru) | 1985-05-30 | 1986-05-29 | Способ получени амидов или их кислотноаддитивных солей |
SU874202112A SU1470183A3 (ru) | 1985-05-30 | 1987-03-09 | Способ получени амидных производных хинолина или их солей присоединени кислоты |
SU874202412A SU1614759A3 (ru) | 1985-05-30 | 1987-04-06 | Способ получени амидов, их диастериомеров, рацематов, энантиомеров или их аддитивных солей |
SU874202398A SU1537135A3 (ru) | 1985-05-30 | 1987-04-06 | Способ получени амидов хиназолина |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU874202362A SU1544186A3 (ru) | 1985-05-30 | 1987-04-06 | Способ получени амидов |
Country Status (20)
Country | Link |
---|---|
US (3) | US4788204A (ru) |
EP (2) | EP0210084B1 (ru) |
JP (2) | JPS625946A (ru) |
AT (2) | ATE47840T1 (ru) |
AU (2) | AU579473B2 (ru) |
CA (2) | CA1251206A (ru) |
DE (2) | DE3662045D1 (ru) |
DK (2) | DK252386A (ru) |
ES (7) | ES8704731A1 (ru) |
FR (1) | FR2582514B1 (ru) |
GR (2) | GR861368B (ru) |
HU (2) | HU195642B (ru) |
IL (2) | IL78969A (ru) |
MA (2) | MA20696A1 (ru) |
NO (2) | NO862133L (ru) |
NZ (2) | NZ216331A (ru) |
PT (2) | PT82674B (ru) |
SU (7) | SU1508957A3 (ru) |
TN (2) | TNSN86080A1 (ru) |
ZA (2) | ZA863993B (ru) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4876346A (en) * | 1985-05-02 | 1989-10-24 | American Home Products Corporation | Quinoline compounds |
FR2582514B1 (fr) * | 1985-05-30 | 1988-02-19 | Rhone Poulenc Sante | Medicaments a base d'amides, nouveaux amides et leur preparation |
HU199423B (en) * | 1987-04-24 | 1990-02-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing 3-amino-4-/ethylthio/-quinoline and pharmaceutical compositions comprising such compounds |
HU199424B (en) * | 1987-04-24 | 1990-02-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing quinoline thioethers and pharmaceutical compositions comprising such compounds |
GB8726735D0 (en) * | 1987-11-14 | 1987-12-16 | Wellcome Found | Pesticidal compounds |
US5081121A (en) * | 1988-05-24 | 1992-01-14 | Tatsushi Osawa | 4(1h)-quinolone derivatives |
FR2636327A1 (fr) * | 1988-09-13 | 1990-03-16 | Rhone Poulenc Sante | Derives de quinoleine, leurs procedes de preparation et les medicaments les contenant |
JP2669905B2 (ja) * | 1989-09-01 | 1997-10-29 | ファナック株式会社 | リレーの溶着検出方法 |
FR2665159B1 (fr) * | 1990-07-24 | 1992-11-13 | Rhone Poulenc Sante | Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent. |
NO932130L (no) * | 1992-06-19 | 1993-12-20 | Lilly Co Eli | Hemmere av HIV-protease som er nyttige for behandling av AIDS |
JP3408300B2 (ja) * | 1993-11-10 | 2003-05-19 | シチズン時計株式会社 | プリンタ |
DE4420337A1 (de) * | 1994-06-10 | 1995-12-14 | Bayer Ag | N-Heterocyclyl-heteroaryloxyacetamide |
US5658902A (en) * | 1994-12-22 | 1997-08-19 | Warner-Lambert Company | Quinazolines as inhibitors of endothelin converting enzyme |
IL117659A (en) * | 1995-04-13 | 2000-12-06 | Dainippon Pharmaceutical Co | Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same |
US5648448A (en) * | 1995-06-06 | 1997-07-15 | Hitachi Chemical Company, Ltd. | Method of preparation of polyquinolines |
US5776946A (en) * | 1995-08-28 | 1998-07-07 | Mcgeer; Patrick L. | Peripheral benzodiazepine receptor ligands as antiinflammatory agents |
FR2750427B1 (fr) * | 1996-06-28 | 1998-08-07 | Synthelabo | Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique |
WO1998049900A1 (en) * | 1997-05-07 | 1998-11-12 | Emory University | Haloisoquinoline carboxamide |
ZA9810490B (en) | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
FR2778564B1 (fr) * | 1998-05-13 | 2001-07-13 | Sanofi Sa | Utilisation de composes reduisant l'apoptose |
WO1999058117A1 (fr) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Utilisation de composes reduisant l'apoptose |
FR2779963A1 (fr) * | 1998-06-22 | 1999-12-24 | Centre Nat Rech Scient | Utilisation d'un compose possedant une affinite pour le recepteur mitochondrial des benzodiazepines en therapie du cancer |
WO2000037086A1 (en) | 1998-12-18 | 2000-06-29 | Scios Inc. | Agonists and antagonists of peripheral-type benzodiazepine receptors |
US6297256B1 (en) * | 1999-06-15 | 2001-10-02 | Neurogen Corporation | Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands |
AR026748A1 (es) * | 1999-12-08 | 2003-02-26 | Vertex Pharma | Un compuesto inhibidor de caspasas, una composicion farmaceutica que lo comprende, un metodo para la sintesis del mismo y un compuesto intermediario paradicha sintesis |
EP1110552A1 (en) * | 1999-12-22 | 2001-06-27 | Aventis Pharma S.A. | Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy |
WO2002000623A2 (en) * | 2000-06-26 | 2002-01-03 | Neurogen Corporation | Aryl fused substituted 4-oxy-pyridines |
CN100503572C (zh) * | 2002-06-28 | 2009-06-24 | 沃泰克斯药物股份有限公司 | 天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途 |
CA2511235A1 (en) * | 2002-12-20 | 2004-07-15 | Vertex Pharmaceuticals Incorporated | 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors |
DE60335028D1 (de) * | 2002-12-23 | 2010-12-30 | Icagen Inc | Quinazolinone als kaliumkanalmodulatoren |
PE20050159A1 (es) * | 2003-05-27 | 2005-04-19 | Vertex Pharma | Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa |
US7423176B2 (en) * | 2004-04-13 | 2008-09-09 | Cephalon, Inc. | Bicyclic aromatic sulfinyl derivatives |
EP1889837A1 (en) * | 2006-07-10 | 2008-02-20 | Pharmeste S.r.l. | VR1 vanilloid receptor antagonists with a iononic substructure |
WO2008114002A1 (en) * | 2007-03-22 | 2008-09-25 | Astrazeneca Ab | Quinoline derivatives for the treatment of inflammatory diseases |
US8382751B2 (en) * | 2009-09-10 | 2013-02-26 | Covidien Lp | System and method for power supply noise reduction |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR964545A (ru) * | 1947-04-11 | 1950-08-18 | ||
US2568037A (en) * | 1947-10-24 | 1951-09-18 | Sterling Drug Inc | Tertiary-aminoalkyl esters and amides of 4-quinolylmercaptoalkanoic acids and their preparation |
US2785165A (en) * | 1953-12-22 | 1957-03-12 | Abbott Lab | Preparation of 4-aminoquinoline |
GB1013224A (en) * | 1962-06-21 | 1965-12-15 | Ici Ltd | Heterocyclic aminoethanols |
GB1064252A (en) * | 1963-09-19 | 1967-04-05 | Ici Ltd | Amides and pharmaceutical compositions containing them |
IL26022A (en) * | 1966-06-23 | 1971-06-23 | Haber R | Nitrofuryl quinoline derivatives |
GB1177548A (en) * | 1967-11-28 | 1970-01-14 | Ici Ltd | Phenoxy-and Anilino-Alkanoic Acid Amides |
US3595861A (en) * | 1967-12-08 | 1971-07-27 | American Home Prod | Novel synthesis of 2-quinazolinepropionic acids and derivatives |
FR8411M (ru) * | 1968-12-31 | 1971-03-31 | ||
DE2361438C3 (de) * | 1973-12-10 | 1979-12-13 | Hoechst Ag, 6000 Frankfurt | 4-Hydroxychinoün- und 4-Hydroxytetrahydrochinolin-N^N-dimethylcarbamate, Verfahren zu ihrer Herstellung und diese enthaltende insektizide Mittel |
DE2411662A1 (de) | 1974-03-12 | 1975-09-25 | Lechler Elring Dichtungswerke | Vorrichtung zum einseitigen anheben und lenkbarmachen einer palette insbesondere einer rollpalette |
GB1574019A (en) * | 1977-01-14 | 1980-09-03 | Joullie International Sa | Therapeutically useful 3,4,5-trimethoxybenzene derivatives |
FR2471981A1 (fr) * | 1979-12-21 | 1981-06-26 | Pharmindustrie | Nouveaux derives de la (piperidyl-4)-2 (quinolyl-4)-1 ethanone, produits intermediaires et procedes pour leur preparation, et leur utilisation comme medicaments |
FR2485014A1 (fr) * | 1980-06-20 | 1981-12-24 | Pharmindustrie | Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments |
FR2525595A1 (fr) * | 1982-04-27 | 1983-10-28 | Pharmuka Lab | Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments |
FR2538388B1 (fr) * | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
ZA847673B (en) * | 1983-09-29 | 1985-05-29 | Akzo Nv | Quinazoline and isoquiniline derivatives |
FR2582514B1 (fr) * | 1985-05-30 | 1988-02-19 | Rhone Poulenc Sante | Medicaments a base d'amides, nouveaux amides et leur preparation |
-
1985
- 1985-05-30 FR FR858508111A patent/FR2582514B1/fr not_active Expired
-
1986
- 1986-05-28 PT PT82674A patent/PT82674B/pt not_active IP Right Cessation
- 1986-05-28 PT PT82673A patent/PT82673B/pt not_active IP Right Cessation
- 1986-05-28 AU AU58031/86A patent/AU579473B2/en not_active Ceased
- 1986-05-28 US US06/867,555 patent/US4788204A/en not_active Expired - Fee Related
- 1986-05-28 ZA ZA863993A patent/ZA863993B/xx unknown
- 1986-05-28 GR GR861368A patent/GR861368B/el unknown
- 1986-05-28 NZ NZ216331A patent/NZ216331A/xx unknown
- 1986-05-28 US US06/867,474 patent/US4728647A/en not_active Expired - Fee Related
- 1986-05-28 NZ NZ216330A patent/NZ216330A/xx unknown
- 1986-05-28 ZA ZA863992A patent/ZA863992B/xx unknown
- 1986-05-28 GR GR861369A patent/GR861369B/el unknown
- 1986-05-28 AU AU58030/86A patent/AU579472B2/en not_active Ceased
- 1986-05-29 HU HU862266A patent/HU195642B/hu unknown
- 1986-05-29 DK DK252386A patent/DK252386A/da not_active Application Discontinuation
- 1986-05-29 MA MA20922A patent/MA20696A1/fr unknown
- 1986-05-29 SU SU864027667A patent/SU1508957A3/ru active
- 1986-05-29 IL IL78969A patent/IL78969A/xx unknown
- 1986-05-29 HU HU862265A patent/HU195641B/hu unknown
- 1986-05-29 MA MA20923A patent/MA20697A1/fr unknown
- 1986-05-29 NO NO862133A patent/NO862133L/no unknown
- 1986-05-29 DK DK252286A patent/DK252286A/da not_active Application Discontinuation
- 1986-05-29 AT AT86401141T patent/ATE47840T1/de not_active IP Right Cessation
- 1986-05-29 CA CA000510311A patent/CA1251206A/fr not_active Expired
- 1986-05-29 IL IL78968A patent/IL78968A/xx unknown
- 1986-05-29 CA CA000510308A patent/CA1264160A/fr not_active Expired - Lifetime
- 1986-05-29 SU SU864027526A patent/SU1440342A3/ru active
- 1986-05-29 DE DE8686401140T patent/DE3662045D1/de not_active Expired
- 1986-05-29 AT AT86401140T patent/ATE40689T1/de active
- 1986-05-29 EP EP86401140A patent/EP0210084B1/fr not_active Expired
- 1986-05-29 EP EP86401141A patent/EP0205375B1/fr not_active Expired
- 1986-05-29 NO NO862134A patent/NO862134L/no unknown
- 1986-05-29 DE DE8686401141T patent/DE3666813D1/de not_active Expired
- 1986-05-30 JP JP61123872A patent/JPS625946A/ja active Pending
- 1986-05-30 ES ES555557A patent/ES8704731A1/es not_active Expired
- 1986-05-30 TN TNTNSN86080A patent/TNSN86080A1/fr unknown
- 1986-05-30 TN TNTNSN86081A patent/TNSN86081A1/fr unknown
- 1986-05-30 ES ES555558A patent/ES8704732A1/es not_active Expired
- 1986-05-30 JP JP61123873A patent/JPS6264A/ja active Pending
- 1986-10-31 ES ES557168A patent/ES8705226A1/es not_active Expired
- 1986-10-31 ES ES557169A patent/ES8705227A1/es not_active Expired
- 1986-10-31 ES ES557166A patent/ES8705225A1/es not_active Expired
- 1986-10-31 ES ES557167A patent/ES8800660A1/es not_active Expired
- 1986-10-31 ES ES557170A patent/ES8705228A1/es not_active Expired
-
1987
- 1987-03-09 SU SU874202112A patent/SU1470183A3/ru active
- 1987-04-06 SU SU874202412A patent/SU1614759A3/ru active
- 1987-04-06 SU SU874202398A patent/SU1537135A3/ru active
- 1987-04-06 SU SU874202297A patent/SU1470182A3/ru active
- 1987-04-06 SU SU874202362A patent/SU1544186A3/ru active
-
1988
- 1988-03-11 US US07/167,126 patent/US4788199A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1470182A3 (ru) | Способ получени амидов | |
JPS649985B2 (ru) | ||
HUT41770A (en) | Process for producing indol derivatives containing heterocyclic substituents and pharmaceutical compositions containing them | |
HU198030B (en) | Process for production of derivatives of benzotiasole and benzotiophen and medical preparatives containing these compounds as active substance | |
HU211983A9 (en) | Hydroxamic acid based collagenase inhibitors | |
ZA200605698B (en) | Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics | |
EP0302788A1 (fr) | Dérivés de [(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 9H-pyrido[3,4-b]indole, leur préparation et leur application en thérapeutique | |
PL164480B1 (pl) | Sposób wytwarzania nowych pochodnych aminofenolu PL | |
KR900004385B1 (ko) | 카복사미드 유도체 및 그의 제조방법 | |
JPH04235968A (ja) | 2−クロロピリジン誘導体の製造 | |
NO163583B (no) | Koplingsanordning for maaleinstrumenter. | |
HU184271B (en) | Process for preparing imidazolidine derivatives | |
Bravo et al. | Enantiomerically Pure (z-Fluoroalkyl-ct-Amino Acids: Synthesis of (R)-(x-Difluoromethyl-Alanine and (S)-(x-DifluoromethyI-Serine | |
IE41440B1 (en) | 7-methoxy-6-thiatetracyclines and their preparation | |
EP2473489B1 (en) | 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives | |
US4157340A (en) | N,N'-[Bis(N-cyanoguanyl)]cystamine derivatives | |
AT391865B (de) | Verfahren zur herstellung neuer benzothiophenderivate | |
US5071858A (en) | Antipsychotic benzothiopyranylamines | |
EP1189903B1 (fr) | NOUVEAUX DERIVES DE LA BENZO[f]NAPHTYRIDINE, LEUR PREPARATION ET LES COMPOSITIONS LES CONTENANT | |
IE59783B1 (en) | 1,6-Naphthyridine-derivatives, process for the preparation thereof and pharmaceutical compositions containing them for the treatment of blood vessel diseases | |
JP2005306874A (ja) | パントプラゾールナトリウム塩の多形体およびその製造方法 | |
KR900018082A (ko) | 페닐알카노산의 에스테르 | |
US4198509A (en) | Mercaptoacylpiperazine carboxylic acid compounds | |
EP0446133B1 (fr) | Nouveaux dérivés de la 4H-pyrrolo[1,2-a]thieno[3,2-f][1,4]-diazépine leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
Lukevics et al. | Synthesis and cytotoxicity of silyl-and carbonyl-substituted isoxazoles |